Skip to content

Digital Health VC

Observations by a European Venture Capitalist

Menu
  • Home
  • About
  • Raising VC Guide
Menu

Top 10 Mistakes Digital Health Founders Make When Pitching

Posted on May 25, 2025July 27, 2025 by Min-Sung Sean Kim

Some pitches flop not because the idea is bad, but because the delivery makes investors quietly click the mental “pass” button.

In digital health, this effect is magnified. The stakes are higher. The jargon is thicker. The scrutiny is brutal. Founders walk in with a pitch and walk out thinking the VC just didn’t get it.

Truth is, they got it. You just made one of the 10 classic mistakes that silently kill deals.

Let’s make sure you don’t.


1. Pitching the Total Addressable Market Instead of the Actual Beachhead

“Healthcare is a $4 trillion industry” is not a strategy—it’s a LinkedIn post.

VCs want to know where you’re starting, who your first customers are, and how you wedge into the system. If you can’t explain your beachhead market and why it’s the logical entry point, you’re out.


2. Glossing Over Regulation

Pretending HIPAA doesn’t apply because you’re “just a platform” is a great way to end a pitch fast. Same goes for FDA if you’re skirting the line on a clinical claim.

If you’re unsure, say that. If you’ve mapped it out, show your plan. Compliance doesn’t kill startups—denial does.


3. Ignoring the Buyer

You’re not selling to patients. You’re selling to payers, systems, or employers.

If you don’t clearly articulate who pays, how they pay, and what budget line it comes from, the VC can’t even model your path forward.


4. Too Much Product, Not Enough Problem

Founders love demoing features. But if you don’t hammer the problem first—and show you understand how painful, expensive, or urgent it is—the product becomes irrelevant.

The pitch should be 70% problem, 30% solution.


5. Overhyped Claims with No Evidence

Throwing out phrases like “AI-powered,” “clinical-grade,” or “proprietary algorithm” without proof gets you labeled as noise.

If you’ve got evidence, flaunt it. If you don’t, don’t fake it. Say what’s in motion.


6. Lack of Domain Expertise

No one expects you to be a cardiologist and a full-stack engineer. But if your team doesn’t include people with domain experience—or strong advisory firepower—your credibility takes a hit.

Don’t build in a vacuum. Investors know when you haven’t talked to real users.


7. No Clear Go-to-Market Plan

“We’ll just sell to hospitals” is not a strategy. Hospitals are massive bureaucracies with 18-month procurement cycles.

VCs want to see:

  • Strategic partnerships
  • Distribution hacks
  • Who gets you in the door and why they say yes

8. Confusing Clinical Outcomes With Business Value

Yes, your product might reduce readmissions. But who benefits? Who pays? And how do you prove it?

If you can’t link the clinical impact to a business case, your pitch will land flat.


9. Pretending There’s No Competition

Every founder wants to say, “no one’s doing what we’re doing.” But investors know better.

Even if you’re novel, there’s an incumbent solution—Excel, a human, a workaround. Acknowledge it. Then show why your approach is 10x better.


10. Defensive or Evasive Answers

This one kills deals more than all the others combined.

If you get rattled by hard questions, or brush off concerns with vague promises, you create mistrust. Great founders lean into tough questions—they’ve already asked them themselves.


Wrap-Up: Be the Founder Who’s Real, Sharp, and Prepared

You don’t have to be perfect. But you do have to be credible.

Fix these 10 mistakes and you’ll instantly stand out—not just for the right reasons, but to the right investors.

Want to see what good looks like? Read: What Digital Health VCs Look For in Startups and Ultimate Guide to Raising Venture Capital.


  • Author
  • Recent Posts
Min-Sung Sean Kim
Min-Sung Sean Kim
Min-Sung conducts global growth investments for Allianz X, the Venture Capital unit of Allianz Group, that reaches 75m customers in 80 countries worldwide. Prior to Allianz X he was Partner of a Berlin-based venture capital fund that specialized in Digital Health Series A investments.
He has invested in startups including American Well, Neuronation, Mimi, and most notably mySugr – which was recently acquired by Roche. Min-Sung is also a contributing writer for mediums including TechCrunch and Tech.EU and studied Business Economics at Witten/Herdecke, Harvard, St.Gallen, and in Seoul.
Min-Sung Sean Kim
Latest posts by Min-Sung Sean Kim (see all)
  • House of Pheromones: Where Scent, Science, and Behavior Meet Digital Health - July 27, 2025
  • The Non-Dilutive Funding Guide for Digital Health Startups - July 27, 2025
  • Clinical Validation for Digital Health Startups: Building Trust That Closes Rounds - July 27, 2025
Category: Insider's Perspective

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Min-Sung Sean Kim

About Min-Sung Sean Kim

Digital health investor and startup mentor. Reviewed 2,300+ startups across Europe. Bridging founders and funding through real-world insights and ecosystem experience.

→ Read more

Recent Posts

  • House of Pheromones: Where Scent, Science, and Behavior Meet Digital Health
  • The Non-Dilutive Funding Guide for Digital Health Startups
  • Clinical Validation for Digital Health Startups: Building Trust That Closes Rounds
  • Unit Economics for Digital Health Startups: What VCs Want to See
  • Healthcare Regulations 101 for Digital Health Startups

Categories

  • Compliance & Strategy
  • Digital Health Ecosystem
  • General Thoughts
  • Insider's Perspective
  • New Frontiers In Healthtech
  • About Min-Sung Sean Kim
  • Privacy Policy
  • Terms of Service
  • The Ultimate Guide to Raising Venture Capital for Digital Health Startups
© 2025 Digital Health VC. All rights reserved.